- UroToday Home
- Urologic Oncology
The Latest Bladder Cancer Research
Recent Abstracts
-
Prehabilitation in patients undergoing bladder cancer surgery - A systematic review and meta-analysis.Bladder CancerNovember 1, 2024
-
Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer.Bladder CancerNovember 1, 2024
-
Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancer.Bladder CancerOctober 31, 2024
-
HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevance.Bladder CancerOctober 31, 2024
-
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolutionBladder CancerOctober 30, 2024
-
Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum-containing chemotherapy: Post hoc analysis of KEYNOTE-052 and LEAP-011.Bladder CancerOctober 30, 2024
-
Sex Disparity in Non-muscle-invasive Bladder Cancer: Pitfalls of Large Population-based Data Sets and Lessons from an Integrated Analysis.Bladder CancerOctober 30, 2024
-
Sensitive Detection of Urothelial Cancer via High-volume Urine DNA Analysis.Bladder CancerOctober 30, 2024
-
Altered immunophenotypic expression in the peripheral bladder cancer immune landscape.Bladder CancerOctober 30, 2024
-
Long-term recurrence risk, metastatic potential and length of cystoscopic surveillance of low-grade non-muscle invasive bladder cancer.Bladder CancerOctober 30, 2024
Beyond the Abstracts
-
Comparative Effectiveness of Bacillus Calmette-Guérin and Sequential Intravesical Gemcitabine and Docetaxel for Treatment-naïve Intermediate-risk Non-muscle-invasive Bladder Cancer - Beyond the AbstractBladder CancerOctober 21, 2024
-
Exposures and Bladder Cancer Risk Among Military Veterans: A Systematic Review and Meta-analysis - Beyond the AbstractBladder CancerOctober 21, 2024
-
Early Adjuvant Chemotherapy Improves Survival in Muscle Invasive Bladder Cancer: A Systematic Review and Meta-analysis - Beyond the AbstractBladder CancerOctober 9, 2024
-
Novel Therapeutic Regimens in Previously Untreated Metastatic Urothelial Carcinoma: A Systematic Review and Bayesian Network Meta-Analysis - Beyond the AbstractBladder CancerOctober 7, 2024
-
Perioperative and Extended Outcomes of Patients Undergoing Parastomal Hernia Repair Following Cystectomy and Ileal Conduit - Beyond the AbstractBladder CancerSeptember 26, 2024
-
Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-Line Treatment for Advanced Urothelial Cancer: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials - Beyond the AbstractBladder CancerSeptember 3, 2024
-
Population Estimates of Ovarian Cancer Risk in a Cohort of Patients with Bladder Cancer - Beyond the AbstractBladder CancerSeptember 3, 2024
-
Impact of Pathologic Re-Review on Grade, Clinical Stage, and Risk Stratification for Patients with Non-Muscle Invasive Bladder Cancer - Beyond the AbstractBladder CancerAugust 27, 2024
-
A Podcast on Practical Considerations in Patients with Advanced Urothelial Cancer Receiving First-Line Cisplatin- or Carboplatin-Based Chemotherapy Followed by Avelumab Maintenance in a Changing Therapeutic Landscape - Beyond the AbstractBladder CancerAugust 8, 2024
-
Survival of Metastatic Urothelial Carcinoma of Urinary Bladder According to Number and Location of Visceral Metastases - Beyond the AbstractBladder CancerAugust 5, 2024
